LINFOLIN (Tablet)

LINFOLIN is a high-potency tablet formulation containing Ferrous Ascorbate 100 mg + Folic Acid 1.5 mg + Zinc Sulphate Monohydrate 22.5 mg.

Composition: Ferrous Ascorbate 100 mg + Folic Acid 1.5 mg + Zinc Sulphate Monohydrate 22.5 mg
Dosage Form: Tablet

Clinical Pharmacology

LINFOLIN provides iron, folate and zinc. Iron is essential for hemoglobin synthesis and oxygen transport. Folic acid supports DNA synthesis and erythropoiesis. Zinc contributes to cellular metabolism and immune function.

Indications & Usage

May be used for:

• Iron deficiency
• Iron deficiency anemia
• Folate deficiency-associated nutritional anemia
• Increased iron requirements
• Nutritional supplementation during pregnancy and reproductive years, when prescribed
• Nutritional support in individuals with increased micronutrient requirements

Contraindications

• Hypersensitivity
• Iron overload disorders
• Hemochromatosis or hemosiderosis

Warnings & Precautions

Use cautiously in patients with gastrointestinal disorders or disorders of iron metabolism.

Drug Interactions

Iron may reduce absorption of tetracyclines, quinolones, levothyroxine and certain other medicines. Appropriate dose separation may be necessary.

Pregnancy & Lactation

Can be used when clinically indicated and prescribed during pregnancy and lactation.

Dosage & Administration

As directed by the physician.

Adverse Reactions

Nausea, constipation, abdominal discomfort, diarrhea and dark-colored stools.

Therapeutic Focus: Pregnancy & Maternal Nutrition | Primary Specialty: Gynecology